Arena Pharmaceuticals (ARNA) Stock: Climbing On Licensing Agreement

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is having an incredibly strong start to the trading session in the pre-market hours this morning after the company announced that it has entered into a licensing agreement with United Therapeutics Corporation (UTHR). Of course, the news excited investors, sending the stock on a run for the top. Today, we’ll … Read more

Arena Pharmaceuticals (ARNA) Stock: Flying On Positive Data

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is having an incredibly strong start to the trading session this morning, and for good reason. In the after-hours session last night, the company reported results from a key Phase 2 clinical trial. The results were positive, leading to excitement among investors and sending the stock screaming for the top. Today, … Read more

Arena Pharmaceuticals (ARNA) Stock: Here’s What You Need To Know

Arena Pharmaceuticals (NASDAQ:ARNA) Arena Pharmaceuticals has been struggling to stay afloat as a company, especially with Belviq under performing in the obesity market. Thing are about to get worse because now it will have to go back to the drawing board. In other words, it has admitted that Belviq is not taking off in the … Read more